ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 204 filers reported holding ARCUS BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 2.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,936,782 | -11.6% | 1,612,077 | 0.0% | 18.14% | +3.6% |
| Q2 2023 | $32,741,284 | +11.3% | 1,612,077 | 0.0% | 17.51% | -8.6% |
| Q1 2023 | $29,404,284 | -11.8% | 1,612,077 | 0.0% | 19.15% | +8.0% |
| Q4 2022 | $33,337,752 | -20.9% | 1,612,077 | 0.0% | 17.74% | -23.4% |
| Q3 2022 | $42,172,000 | +3.2% | 1,612,077 | 0.0% | 23.15% | -6.2% |
| Q2 2022 | $40,850,000 | -19.7% | 1,612,077 | 0.0% | 24.66% | +9.0% |
| Q1 2022 | $50,877,000 | -22.0% | 1,612,077 | 0.0% | 22.64% | +14.2% |
| Q4 2021 | $65,241,000 | +1.6% | 1,612,077 | -12.5% | 19.83% | +15.2% |
| Q3 2021 | $64,233,000 | +27.0% | 1,842,077 | 0.0% | 17.21% | +70.7% |
| Q2 2021 | $50,583,000 | -2.2% | 1,842,077 | 0.0% | 10.08% | -15.0% |
| Q1 2021 | $51,726,000 | +8.2% | 1,842,077 | 0.0% | 11.86% | -40.7% |
| Q4 2020 | $47,820,000 | +51.5% | 1,842,077 | 0.0% | 19.99% | +31.6% |
| Q3 2020 | $31,573,000 | -30.7% | 1,842,077 | 0.0% | 15.19% | -7.8% |
| Q2 2020 | $45,573,000 | +78.2% | 1,842,077 | 0.0% | 16.47% | +31.2% |
| Q1 2020 | $25,568,000 | +37.4% | 1,842,077 | 0.0% | 12.55% | +33.0% |
| Q4 2019 | $18,605,000 | – | 1,842,077 | – | 9.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |